Statistics
Publications
3
Citations
911
H-Index
3
Active since
2018
Affiliations
Collins Cheruiyot is an author at Dana-Farber Cancer Institute specializing in resistance to checkpoint inhibitors, immune checkpoint blockade resistance, and cancer immunology.
Publications per year
2018–2023
3
3
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 715 citations · Full text
Medicine, Cancer Biology, Oncology +14
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 174 citations · Full text
1–3 of 3